1. Michael Silbermann, Technion-Israel Institute of Technology, Middle East Cancer Consortium, Haifa; Lea Baider, Assuta Medical Center, Tel Aviv, Israel; Michel Daher, University of Balamand, Saint George Hospital, Beirut, Lebanon; Rejin Kebudi, Oncology Institute, Istanbul, Turkey; Omar Nimri, Ministry of Health, Amman, Jordan; and Mazin Al-Jadiry, Children's Welfare Teaching Hospital, Medical City, Baghdad, Iraq.